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more, but at that time the realization of the
possible risk of liver angiosarcoma associated
with severe exposure led to the lowering of
the permissible levels to a maximum of very
few parts/106. This background reveals an
extensive analytico-chemical problem area.
In the present monograph, an impressive
body of experts has now sought: (i) to critic-
ally evaluate techniques for measuring and
monitoring vinyl chloride; (ii) to recommend
reliable methods of analysis for the deter-
mination (a) of vinyl chloride in air by gas
chromatography (GC), (b) of the 8h time-
weighted average concentration of vinyl
chloride in the atmosphere, using either a
personal sampler pump and a carbon trap or
a personal monitor equipped with detector
tube, (c) of traces of vinyl chloride in air by
trapping followed by GC, (d) ofthe 24h time-
weighted average concentration of vinyl
chloride in air by trapping followed by GC,
and (e) of vinyl chloride in aqueous liquids,
in poly(vinyl chloride) and in food by head-
space sampling followed by GC.
It is rather disappointing that the measure-
ment of pertinent vinyl chloride metabolites
(viz. N-acetyl-S-(2-hydroxyethyl)cysteine and
thiodiglycollic acid) in the body fluids of
exposed subjects is unmentioned, as this
would have introduced the powerful tech-
niques of GC-mass spectrometry and mass
fragmentometry that are available for the
purpose.
D. E. HATHWAY
The Chemistry of Antitumour Anti-
biotics, Vol. I. W. A. REMERS (1979). John
Wiley & Sons, vii+289 pp. £20.45.
This is a detailed account of the work
undertakeninthe5 majorgroupsofantibiotics
that have been shown to have antitumour
activity. The emphasis is on the chemistry of
these agents, with clear structural formulae,
their synthesis and properties, with detailed
listings of their antitumour activities in the
standard tumour systems ofP388 and L1210,
as well as distribution data in different
animal species.
This first volume deals in detail with the
actinomycins, anthracyclines, aureolic acid
group (mithramycins), bleomycin and phleo-
mycin, and the mitomycins and porfiro-
mycins.
The work effectively summarizes the in-
formation up to 1978, and a subsequent
volume is intended to cover antitumour anti-
biotics not yet described. There is an ex-
cellent detailed index, and the book is highly
commended as a valuable reference source
and an inspiration for experimental chemo-
therapist and medical oncologist alike, con-
cerned with the development and application
of this important field of antitumour agents.
B. W. Fox
Advances in Cancer Chemotherapy. Eds
S. K. CARTER, A. GOLDIN, K. KURETANI,
G. MATHE, Y. SAKURAI, S. TUSKAGOSHI and
H. UMEZAWA (1979). Tokyo: Japan Scien-
tific Societies Press. 506 pp. £40.95.
This book presents the proceedings of the
8th International Symposium of the Princess
Takamatsu Cancer Research Fund, Tokyo,
1977. The chapters are a mixture of reviews
by leading authorities onthe clinical approach
to the treatment of various forms of cancer
and detailed experimental data, mainly con-
cerned with the pharmacology of anti-cancer
drugs. The book is now 2 years out of date.
There is a major and interesting contribution
by the Japanese, with a heavy emphasis on
antibiotic anti-cancer therapy. Umezawa re-
views this approach and discusses new agents
which enhance tumour immunity. Ichikawa
discusses the bleomycins and Hata the
mitomycins. I found these articles useful
since the Japanese literature is not readily
available to us. Reviews of the platinum
compounds, nitrosoureas and folate antago-
nists, although by leading authorities, are less
useful since several reviews of this nature
have already been published. General reviews
on approaches to the long-term control of
acute leukaemia, and chemotherapy (Frei-
reich), advances in breast cancer (Bonadonna)
and testicular cancer (Muggia) were all well
written but, again, reviews have recently been
published by these authors or other leading
authorities.
For these reasons I do not feel this book is
a necessary purchase for an individual
medical oncologist or experimental chemo-
therapist, but would prove useful for the next
2 years or so in a library used by oncologists
and those interested in anti-cancer chemo-
therapy.
D. CROWTHER